2018
DOI: 10.1002/eji.201847636
|View full text |Cite
|
Sign up to set email alerts
|

Decreased allergy incidence in children supplemented with E. coli O83:K24:H31 and its possible modes of action

Abstract: The growing knowledge of the key role of microbiota in the maturation of neonatal immune system suggests that manipulation of microbiota could be exploited in hampering allergy development. In this study, Escherichia coli O83:K24:H31 (EcO83) was administered to newborns that were followed prospectively. Several immunological characteristics (cytokines, specific IgE, total T regulatory cells (Treg) and subpopulation of natural Treg (nTreg) and induced Treg (iTreg)) were tested in peripheral blood of 8-year-old … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
12
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 11 publications
(17 citation statements)
references
References 63 publications
2
12
0
3
Order By: Relevance
“…Several studies have correlated population characteristics and functional properties of Tregs with atopic diseases in small infants [16,[24][25][26][27]. In our own work published by Hrdý in 2012 [17], we reported lower presence of intracellular markers associated with Treg function (IL-10, TGF-β, MFI of FoxP3) in Tregs from cord blood of children at higher risk of allergy development (based on maternal allergy status).…”
Section: Introductionmentioning
confidence: 57%
See 2 more Smart Citations
“…Several studies have correlated population characteristics and functional properties of Tregs with atopic diseases in small infants [16,[24][25][26][27]. In our own work published by Hrdý in 2012 [17], we reported lower presence of intracellular markers associated with Treg function (IL-10, TGF-β, MFI of FoxP3) in Tregs from cord blood of children at higher risk of allergy development (based on maternal allergy status).…”
Section: Introductionmentioning
confidence: 57%
“…presence of surface or intracellular markers, median of fluorescence intensity [MFI] of FoxP3 [14]) and systemically (e.g. levels of regulatory cytokines in serum measured by ELISA [15,16]).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…This treatment also diminishes NF-κB cascade function and IL-8 levels, while increasing IL-10 concentration in the colon [ 168 ]. Neonatal therapy with E. coli O83:K24:H31 reduces allergy rates, augments T regulatory cells and elevates their IL-10 expression, as well as raising serum IL-10 and IFN-γ levels in children [ 169 ]. Treatment with Bifidobacterium bifidum TMC3115 during the neonatal period augments fecal bacterial variety, caecal SCFAs generation and Bacteroidetes prevalence.…”
Section: Important Immune Mediators During the Neonatal Periodmentioning
confidence: 99%
“…Nevertheless, despite the progress in our understanding of the early etiopathology of allergy development, few reliable predictors of individual risk have been conclusively identified so far. Various factors have been studied without much success, including cord blood IgE [29,30], levels of IL-10, TGF-β and/or Th1-and Th2-related cytokines in cord blood [31,32] and neonatal peripheral blood plasma [33], as well as the reactivity of cord blood-derived cells to diverse stimuli under various conditions [34][35][36][37][38]. So far, parental allergy status, especially maternal or biparental allergy, seems to be the most reliable predictor of risk for allergy development at an individual level [38,39].…”
Section: Introductionmentioning
confidence: 99%